Immunostaining
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HEK293/Human TrkB Stable Cell Line | Anmelden | HEK293/Human TrkB Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| NY-ESO-1 specific TCR-HEK293 cell line | Anmelden | NY-ESO-1 specific TCR-HEK293 cell line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/FcRn (FCGRT & B2M), GFP Tag Stable Cell Line | Anmelden | HEK293/FcRn (FCGRT & B2M), GFP Tag Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human Anti-CD19 Stable Cell Line | Anmelden | HEK293/Human Anti-CD19 Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human ASGR1 Stable Cell Line | Anmelden | HEK293/Human ASGR1 Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human GPRC5D Stable Cell Line | Anmelden | HEK293/Human GPRC5D Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human 4-1BB / TNFRSF9 Stable Cell Line | Anmelden | HEK293/Human 4-1BB / TNFRSF9 Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human OX40 Ligand Stable Cell Line | Anmelden | HEK293/Human OX40 Ligand Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human Transferrin R Stable Cell Line | Anmelden | HEK293/Human Transferrin R Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| Human Soluble NT5E/CD73 ELISA Kit, PRO | Anmelden | Human Soluble NT5E/CD73 ELISA Kit, PRO | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (UCHT1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) | Anmelden | Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2) | ||||||||||||||||
|
||||||||||||||||||
| HEK293/Human NKp46 Stable Cell Line | Anmelden | HEK293/Human NKp46 Stable Cell Line | ||||||||||||||||
|
||||||||||||||||||
| Biotinylated Anti-His Tag Antibody(AY63), Fab (MALS verified) | Anmelden | Biotinylated Anti-His Tag Antibody(AY63), Fab (MALS verified) | ||||||||||||||||
|
||||||||||||||||||
| HRP conjugated Anti-His Antibody (AY63), mAb | Anmelden | HRP conjugated Anti-His Antibody (AY63), mAb | ||||||||||||||||
|
||||||||||||||||||
| HRP conjugated Anti-His Antibody (AY63), mAb | Anmelden | HRP conjugated Anti-His Antibody (AY63), mAb | ||||||||||||||||
|
||||||||||||||||||
| Biotinylated Anti-His Tag Antibody(AY63), Fab (MALS verified) | Anmelden | Biotinylated Anti-His Tag Antibody(AY63), Fab (MALS verified) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) (MALS verified) | Anmelden | Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) (MALS verified) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) (MALS verified) | Anmelden | Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) (MALS verified) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) (MALS verified) | Anmelden | Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) (MALS verified) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) (MALS verified) | Anmelden | Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) (MALS verified) | ||||||||||||||||
|
||||||||||||||||||


